[Attempt at treating multiple sclerosis with delayed-action corticotropin].
D015068:17-Ketosteroids / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000138:chemical synthesis / Q000627:therapeutic use*; D000328:Adult; D003692:Delayed-Action Preparations; D004342:Drug Hypersensitivity / Q000209:etiology; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D012882:Skin Tests
D015068:17-Ketosteroids; D003692:Delayed-Action Preparations; D007166:Immunosuppressive Agents; D000324:Adrenocorticotropic Hormone
Próba leczenia chorych na stwardnienie rozsiane syntetyczna kortykotropina o przedłuzonym działaniu.